Parvathi Ranganathan

The University of Arizona, Tucson, AZ, USA

Are you Parvathi Ranganathan?

Claim your profile

Publications (2)6.13 Total impact

  • Article: Somatic hypermutation of TCR γ V genes in the sandbar shark.
    Hao Chen, Harris Bernstein, Parvathi Ranganathan, Samuel F Schluter
    [show abstract] [hide abstract]
    ABSTRACT: In a recent publication we demonstrated that somatic hypermutation occurs in the V region of the TCR γ gene of the sandbar shark (Carcharhinus plumbeus). We hypothesize that similar mechanisms are used to generate somatic mutations in both immunoglobulin and TCR γ genes of the sharks. Two distinct patterns of mutation occur, single nucleotide mutations (point mutations) and mutations comprising 2-5 consecutive bases (tandem mutations). Our data indicates that point mutations occur by a mechanism similar to that of somatic hypermutation in immunoglobulin genes of mammals, whereas tandem mutations may be generated by an error-prone DNA polymerase with terminal deoxynucleotidyl transferase (TdT)-like activity. Shark hotspot motifs identical to those of higher vertebrates were identified. We confirm that, as in immunoglobulin of sharks and higher vertebrates, highly significant targeting of AID activity to the classical DGYW/WRCH motif occurs in somatic hypermutation of sandbar shark TCR γ V genes. Our analysis suggests that the purpose of somatic mutations in shark TCR γ V-regions is to generate a more diverse repertoire in γ/δ receptors, rather than receptors with higher affinity.
    Developmental and comparative immunology 09/2011; 37(1):176-83. · 3.29 Impact Factor
  • Article: Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity.
    Parvathi Ranganathan, Hao Chen, Miranda K Adelman, Samuel F Schluter
    [show abstract] [hide abstract]
    ABSTRACT: In this report, we show that affinity purified human anti-delta opioid receptor (DOR) autoantibodies from IVIG are specific to DOR and possess agonistic properties displayed by their ability to dramatically decrease forskolin stimulated cAMP accumulation. Anti-DOR autoantibody also caused phosphorylation of the opioid receptor. Anti-DOR autoantibody treatment showed a significant reduction in CXCR4 gene expression as well as surface protein expression. In contrast, anti-DOR autoantibody treatment significantly upregulated CCR5 gene and protein expression. The presence of anti-DOR autoantibodies in IVIG and their potent immunomodulatory activity is further evidence to support the cross-talk between the neuroendocrine and immune systems.
    Journal of neuroimmunology 10/2009; 217(1-2):65-73. · 2.84 Impact Factor